EuroEyes International Eye Clinic Limited released its Monthly Return for Equity Issuer for the period ended 31 August 2026, indicating a stable capital structure with full adherence to Hong Kong Stock Exchange public-float requirements.

Authorised and Registered Capital • The company’s authorised share capital remained unchanged at USD 10.00 million, corresponding to 1.00 billion ordinary shares with a par value of USD 0.01 each.

Issued Share Capital and Treasury Shares • Issued shares stood at 320.71 million, identical to the previous month’s level. • EuroEyes held no treasury shares, keeping total issued shares at 320.71 million.

Public-Float Position • The company confirmed compliance with the Main Board’s minimum public-float threshold of 25% as of 31 August 2026.

Capital Movements • No share options, warrants, convertible instruments, or other equity-linked agreements were issued, exercised, or outstanding during the month. • There were no share repurchases, cancellations, redemptions, or other alterations to the share count.

Governance Confirmation • The filing, signed by Company Secretary Rosenna Ho on 1 September 2026, states that all statutory and regulatory obligations related to securities issuance and listing have been met.

Overall, EuroEyes reported a steady share capital position through August 2026, with no dilution events and continued compliance with Hong Kong listing regulations.